Across TCGA pan-cancer cohorts, RNA5SP447 RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of RNA5SP447’s most consistent transcriptional readouts.

The strongest signal is observed in stomach adenocarcinoma (STAD), where RNA5SP447 RNA is repressed in tumor relative to normal tissue. In most cancer types RNA5SP447 is over-expressed in tumor, although a few such as STAD show the opposite, repressed pattern.

STAD and STAD are the cancer types where RNA5SP447 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RNA5SP447 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
STAD	Female	III,IV	−0.980	.039	1	view →
STAD	Male	All	+0.111	.017	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 1 lineages.

Exploration

Same gene, other analysis: RNA5SP447 RNA expression & survival · all RNA5SP447 data types